PMID: 41632158

Outcomes of Anastrozole, Letrozole, and Exemestane in Patients With Postmenopausal Breast Cancer.

Dumas Elise, Hamy Anne-Sophie, Wanis Kerollos Nashat, Jochum Floriane, Coussy Florence, Giacchetti Sylvie, Gaillard Thomas, Laas Enora, Houzard Sophie, Le Bihan-Benjamin Christine

JAMA network open · 2026

Vol. 8, Issue 12, pp. e2550842

This entry links to third-party literature. For research use only.